Capricor Therapeutics Inc logo

Capricor Therapeutics Inc

1
NAS:CAPR (USA)  
$ 14.01 -0.12 (-0.85%) 01:00 PM EST
At Loss
P/B:
8.36
Market Cap:
$ 642.49M
Enterprise V:
$ 511.37M
Volume:
333.70K
Avg Vol (2M):
1.45M
Trade In:
Volume:
333.70K
At Loss
Avg Vol (2M):
1.45M

Business Description

Description
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
Name Current Vs Industry Vs History
Cash-To-Debt 51.56
Equity-to-Asset 0.73
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.6
Distress
Grey
Safe
Beneish M-Score -2.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.24
9-Day RSI 45.89
14-Day RSI 43.69
6-1 Month Momentum % 296.17
12-1 Month Momentum % 318.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.19
Quick Ratio 4.19
Cash Ratio 4.15
Days Sales Outstanding 37.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.8
Shareholder Yield % -14.66

Financials (Next Earnings Date:2025-02-28 Est.)

CAPR's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CAPR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Capricor Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 23.228
EPS (TTM) ($) -1.02
Beta 0.88
Volatility % 245.31
14-Day RSI 43.69
14-Day ATR ($) 1.523162
20-Day SMA ($) 15.2845
12-1 Month Momentum % 318.43
52-Week Range ($) 3.52 - 23.4
Shares Outstanding (Mil) 45.47

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Capricor Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Capricor Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Capricor Therapeutics Inc Frequently Asked Questions

What is Capricor Therapeutics Inc(CAPR)'s stock price today?
The current price of CAPR is $14.01. The 52 week high of CAPR is $23.40 and 52 week low is $3.52.
When is next earnings date of Capricor Therapeutics Inc(CAPR)?
The next earnings date of Capricor Therapeutics Inc(CAPR) is 2025-02-28 Est..
Does Capricor Therapeutics Inc(CAPR) pay dividends? If so, how much?
Capricor Therapeutics Inc(CAPR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1